Publications by authors named "F Chiambaretta"
Article Synopsis
- A study assessed the efficacy and safety of a new eye drop (T2769) for dry eye patients, involving 62 participants treated for 42 days.
- The results showed a significant improvement in ocular symptoms, with a notable reduction in discomfort and a high satisfaction rate among patients.
- T2769 was well tolerated, with minimal side effects and considerable improvement in all evaluated symptoms by the end of the study.
Purpose: To compare the safety of a standardized, commercially available intracameral combination of mydriatics and anesthetic (ICMA) with a reference topical mydriatic regimen for cataract surgery.
Patients And Methods: The safety results from two international, randomized, controlled clinical studies were combined to compare ICMA at the beginning of cataract surgery (ICMA group) to the reference topical mydriatic regimen (reference group). Data were collected on ocular and systemic adverse events, corneal and anterior chamber examination, endothelial cell density, retinal thickness and visual acuity.
Article Synopsis
- Universal mask-wearing significantly reduces SARS-CoV-2 transmission, particularly in enclosed spaces and healthcare settings, but there are concerns about potential infection risks associated with eye exposure during medical procedures.* -
- Evidence suggests that improper mask fit may cause airflow towards the eyes, leading to issues like dry eye, ocular inflammation, and a potential risk of intraocular infections.* -
- While prolonged mask use can be linked to increased incidents of ocular problems, further research is needed to differentiate between effects caused by face masks and other factors impacting eye health during the COVID-19 pandemic.*
Article Synopsis
- * The patient's uveitis included severe symptoms like decreased vision and inflammatory changes in both eyes, which did not improve with various standard treatments.
- * Tocilizumab successfully brought the patient's uveitis into remission and was effective even one year later while on a low dose of prednisone, suggesting its potential as a valuable treatment option for uveitis related to MS.